The DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.
Divergent Tumor Necrosis Factor Receptor–Related Remodeling Responses in Heart Failure: Role of Nuclear Factor-κB and Inflammatory Activation
Open accessAbstract
Background— Although preclinical data suggested that tumor necrosis factor-α (TNF) neutralization in heart failure (HF) would be beneficial, clinical trials of TNF antagonists were paradoxically negative. We hypothesized that TNF induces opposing inflammatory and remodeling responses in HF that are TNF-receptor (TNFR) specific. Methods and Results— HF was induced in wild-type (WT), TNFR1 −/− , and TNFR2 −/− mice via coronary ligation. Compared with WT HF, 4-week postinfarction survival was significantly improved in both TNFR1 −/− and TNFR2 −/− HF. Compared with sham, WT HF hearts exhibited significant remodeling with robust activation of nuclear factor (NF)-κB, p38 mitogen-activated protein kinase, and JNK2 and upregulation of TNF, interleukin (IL)-1β, IL-6, and IL-10. Compared with WT HF, TNFR1 −/− HF exhibited (1) improved remodeling, hypertrophy, and contractile function; (2) less apoptosis; and (3) diminished NF-κB, p38 mitogen-activated protein kinase, and JNK2 activation and cytokine expression. In contrast, TNFR2 −/− HF showed exaggerated remodeling and hypertrophy, increased border zone fibrosis, augmented NF-κB and p38 mitogen-activated protein kinase activation, higher IL-1β and IL-6 gene expression, greater activated macrophages, and greater apoptosis. Oxidative stress and diastolic function were improved in both TNFR1 −/− and TNFR2 −/− HF. In H9c2 cardiomyocytes, sustained NF-κB activation was proapoptotic, an effect dependent on TNFR1 signaling, whereas TNFR2 overexpression attenuated TNF-induced NF-κB activation. Conclusions— TNFR1 and TNFR2 have disparate and opposing effects on remodeling, hypertrophy, NF-κB, inflammation, and apoptosis in HF: TNFR1 exacerbates, whereas TNFR2 ameliorates, these events. However, signaling through both receptors is required to induce diastolic dysfunction and oxidative stress. TNFR-specific effects in HF should be considered when therapeutic anti-TNF strategies are developed.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT Method
Livak, K. J., & Schmittgen, T. D. (2001) · Methods · doi:10.1006/meth.2001.1262 · Cited by 180,860
Kyriakis, J. M., & Avruch, J. (2001) · Physiological Reviews · doi:10.1152/physrev.2001.81.2.807 · Cited by 3,382
Signalling pathways of the TNF superfamily: a double-edged sword
Aggarwal, B. B. (2003) · Nature Reviews Immunology · doi:10.1038/nri1184 · Cited by 2,793
Tumor necrosis factor signaling
Wajant, H., Pfizenmaier, K., & Scheurich, P. (2003) · Cell Death & Differentiation · doi:10.1038/sj.cdd.4401189 · Cited by 2,359
Pfeffer, K., Matsuyama, T., Kündig, T. M., Wakeham, A., Kishihara, K., Shahinian, A., Wiegmann, K., Ohashi, P. S., Krönke, M., & Mak, T. W. (1993) · Cell · doi:10.1016/0092-8674(93)90134-c · Cited by 1,677
Tumor Necrosis Factor-α and Tumor Necrosis Factor Receptors in the Failing Human Heart
Torre-Amione, G., Kapadia, S., Lee, J., Durand, J.-B., Bies, R. D., Young, J. B., & Mann, D. L. (1996) · Circulation · doi:10.1161/01.cir.93.4.704 · Cited by 989
Inflammatory Mediators and the Failing Heart: Past, Present, and the Foreseeable Future
Mann, D. L. (2002) · Circulation Research · doi:10.1161/01.res.0000043825.01705.1b · Cited by 988
IKK/NF- B signaling: balancing life and death - a new approach to cancer therapy
Luo, J.-L. (2005) · Journal of Clinical Investigation · doi:10.1172/jci26322 · Cited by 878
Bozkurt, B., Kribbs, S. B., Clubb, F. J., Michael, L. H., Didenko, V. V., Hornsby, P. J., Seta, Y., Oral, H., Spinale, F. G., & Mann, D. L. (1998) · Circulation · doi:10.1161/01.cir.97.14.1382 · Cited by 821
Erickson, S. L., de Sauvage, F. J., Kikly, K., Carver-Moore, K., Pitts-Meek, S., Gillett, N., Sheehan, K. C. F., Schreiber, R. D., Goeddel, D. V., & Moore, M. W. (1994) · Nature · doi:10.1038/372560a0 · Cited by 588
The c-jun kinase/stress-activated pathway: Regulation, function and role in human disease
Johnson, G. L., & Nakamura, K. (2007) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2006.12.009 · Cited by 500
Kurrelmeyer, K. M., Michael, L. H., Baumgarten, G., Taffet, G. E., Peschon, J. J., Sivasubramanian, N., Entman, M. L., & Mann, D. L. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.070036297 · Cited by 440
Cytokine-Induced Modulation of Cardiac Function
Prabhu, S. D. (2004) · Circulation Research · doi:10.1161/01.res.0000150734.79804.92 · Cited by 375
Self-citationMatsumura, S.-I., Iwanaga, S., Mochizuki, S., Okamoto, H., Ogawa, S., & Okada, Y. (2005) · Journal of Clinical Investigation · doi:10.1172/jci200522304 · Cited by 339
Li, Y. Y., Feng, Y. Q., Kadokami, T., McTiernan, C. F., Draviam, R., Watkins, S. C., & Feldman, A. M. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.23.12746 · Cited by 324
Wong, S. C. Y., Fukuchi, M., Melnyk, P., Rodger, I., & Giaid, A. (1998) · Circulation · doi:10.1161/01.cir.98.2.100 · Cited by 322
Sun, M., Dawood, F., Wen, W.-H., Chen, M., Dixon, I., Kirshenbaum, L. A., & Liu, P. P. (2004) · Circulation · doi:10.1161/01.cir.0000147233.10318.23 · Cited by 275
Prabhu, S. D., Chandrasekar, B., Murray, D. R., & Freeman, G. L. (2000) · Circulation · doi:10.1161/01.cir.101.17.2103 · Cited by 265
Self-citationMoe, G. W., Marin-Garcia, J., Konig, A., Goldenthal, M., Lu, X., & Feng, Q. (2004) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00036.2004 · Cited by 162
Blockade of NF-κB improves cardiac function and survival after myocardial infarction
Kawano, S., Kubota, T., Monden, Y., Tsutsumi, T., Inoue, T., Kawamura, N., Tsutsui, H., & Sunagawa, K. (2006) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.01175.2005 · Cited by 155
Monden, Y., Kubota, T., Inoue, T., Tsutsumi, T., Kawano, S., Ide, T., Tsutsui, H., & Sunagawa, K. (2007) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00166.2007 · Cited by 153
Skyschally, A., Gres, P., Hoffmann, S., Haude, M., Erbel, R., Schulz, R., & Heusch, G. (2006) · Circulation Research · doi:10.1161/01.res.0000255031.15793.86 · Cited by 150
Canton, M., Skyschally, A., Menabò, R., Boengler, K., Gres, P., Schulz, R., Haude, M., Erbel, R. M., Lisa, F. D., & Heusch, G. (2006) · European Heart Journal · doi:10.1093/eurheartj/ehi751 · Cited by 149
Absence of NF‐κB subunit p50 improves heart failure after myocardial infarction
Frantz, S., Hu, K., Bayer, B., Gerondakis, S., Strotmann, J. M., Adamek, A., Ertl, G., & Bauersachs, J. K. (2006) · The FASEB Journal · doi:10.1096/fj.05-5133fje · Cited by 139
Wada, H., Saito, K., Kanda, T., Kobayashi, I., Fujii, H., Fujigaki, S., Maekawa, N., Takatsu, H., Fujiwara, H., Sekikawa, K., et al. (2001) · Circulation · doi:10.1161/01.cir.103.5.743 · Cited by 127
AIP1/DAB2IP, a Novel Member of the Ras-GAP Family, Transduces TRAF2-induced ASK1-JNK Activation
Zhang, H., Zhang, R., Luo, Y., D’Alessio, A., Pober, J. S., & Wang, M. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m407617200 · Cited by 125
SRIVASTAVA, S., CHANDRASEKAR, B., GU, Y., LUO, J., Hamid, T., Hill, B. G., & Prabhu, S. D. (2007) · Cardiovascular Research · doi:10.1016/j.cardiores.2007.02.016 · Cited by 118
Self-citationLuo, J., Hill, B. G., Gu, Y., Cai, J., Srivastava, S., Bhatnagar, A., & Prabhu, S. D. (2007) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00284.2007 · Cited by 105
Self-citationMukherjee, R. D., Mingoia, J. T., Bruce, J. A., Austin, J. S., Stroud, R. E., Escobar, G. P., McClister, D. M., Allen, C. M., Alfonso-Jaume, M., Fini, M. E., et al. (2006) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.01343.2005 · Cited by 77
Ramani, R. N., Mathier, M. A., Wang, P., Gibson, G. A., Tögel, S., Dawson, J., Bauer, A. J., Alber, S. M., Watkins, S. C., McTiernan, C. F., et al. (2004) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00641.2003 · Cited by 64
Iversen, P. O., Nicolaysen, G., & Sioud, M. (2001) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.2001.281.5.h2211 · Cited by 41
Cited by
The Biological Basis for Cardiac Repair After Myocardial Infarction: From Inflammation to Fibrosis
Prabhu, S. D., & Frangogiannis, N. G. (2016) · Circulation Research · doi:10.1161/circresaha.116.303577 · Cited by 2,224
Self-citationThe inflammatory response in myocardial injury, repair, and remodelling
Frangogiannis, N. G. (2014) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2014.28 · Cited by 1,738
The pathogenesis of cardiac fibrosis
Kong, P., Christia, P., & Frangogiannis, N. G. (2014) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-013-1349-6 · Cited by 1,567
Cardiac fibrosis: Cell biological mechanisms, molecular pathways and therapeutic opportunities
Frangogiannis, N. G. (2019) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2018.07.001 · Cited by 841
Pathophysiology of Myocardial Infarction
Frangogiannis, N. G. (2015) · Comprehensive Physiology · doi:10.1002/cphy.c150006 · Cited by 618
Metadata
- Authors
- Hamid, T., Gu, Y., Ortines, R. V., Bhattacharya, C., Wang, G., Xuan, Y.-T., & Prabhu, S. D.
- Venue
- Circulation
- Published
- 2009-03-17
- Volume
- 119
- Issue
- 10
- Pages
- 1386-1397
- ISSN
- 0009-7322 (ISSN-L)
- 1524-4539
- OpenAlex
- W1999015670
- Cited by
- 274
- References
- 31
- FWCI
- 13.05
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.